BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Prognosis
15 results:

  • 1. Brachytherapy for targeting the immune system in cervical cancer patients.
    Linares I; Berenguer Frances MÁ; Cañas R; Najjari D; Gutiérrez C; Marín S; Comas S; Guedea F; Pujol M
    BMC Immunol; 2023 Aug; 24(1):23. PubMed ID: 37559025
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular classification of human papillomavirus-positive cervical cancers based on immune signature enrichment.
    Song G; Luo J; Zou S; Lou F; Zhang T; Zhu X; Yang J; Wang X
    Front Public Health; 2022; 10():979933. PubMed ID: 36203656
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Re-Irradiation for Recurrent cervical cancer: A State-of-the-Art Review.
    Shen Z; Qu A; Jiang P; Jiang Y; Sun H; Wang J
    Curr Oncol; 2022 Jul; 29(8):5262-5277. PubMed ID: 35892987
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Salvage image-guided freehand interstitial brachytherapy for pelvic sidewall recurrence after hysterectomy for uterine malignancies.
    Miyata Y; Murakami N; Okuma K; Shimizu Y; Takahashi A; Kashihara T; Kaneda T; Takahashi K; Inaba K; Sakuramachi M; Kojima K; Aoshika T; Morishima K; Nakayama Y; Itami J; Kato T; Ogo E; Igaki H
    Brachytherapy; 2022; 21(5):647-657. PubMed ID: 35750619
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Assessment of cervical vascularization density in patients with locally advanced squamous cell cervical carcinoma evaluated in colour Doppler and power Doppler functions.
    Tomalczyk A; Tomasik B; Fijuth J; Moszynska-Zielinska M; Gottwald L
    Arch Gynecol Obstet; 2022 Apr; 305(4):955-961. PubMed ID: 34586470
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Treatment Outcome and prognosis Factors of FIGO 2018 Stage III cervical cancer Patients Treated with Definitive Concurrent Chemoradiation in Vietnam.
    Phung HT; Truong MC; Nguyen LT; Dang ATV; Vu TH; Nguyen HT
    Asian Pac J Cancer Prev; 2021 Mar; 22(3):853-859. PubMed ID: 33773550
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comparison of accuracy and long-term prognosis between computed tomography-based and magnetic resonance imaging-based brachytherapy for cervical cancer: A meta-analysis.
    Wang X; Fan L; Yan W; Bao S; Liu L
    J Med Imaging Radiat Oncol; 2020 Feb; 64(1):151-162. PubMed ID: 31845539
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Impact of treatment time-related factors on prognoses and radiation proctitis after definitive chemoradiotherapy for cervical cancer.
    Huang EY; Lin H; Wang CJ; Chanchien CC; Ou YC
    Cancer Med; 2016 Sep; 5(9):2205-12. PubMed ID: 27416796
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Long-term results for Stage IIIB cervical cancer patients receiving external beam radiotherapy combined with either hdr (252)Cf or hdr (60)Co intracavitary brachytherapy.
    Ulinskas K; Janulionis E; Valuckas KP; Samerdokiene V; Atkocius V; Rivard MJ
    Brachytherapy; 2016; 15(3):353-360. PubMed ID: 26996594
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Epithelioid Angiosarcoma of the Bladder: A Series of 9 Cases.
    Matoso A; Epstein JI
    Am J Surg Pathol; 2015 Oct; 39(10):1377-82. PubMed ID: 25929352
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A prospective cohort study to compare treatment results between 2 fractionation schedules of high-dose-rate intracavitary brachytherapy (hdr-ICBT) in patients with cervical cancer.
    Huang EY; Sun LM; Lin H; Lan JH; Chanchien CC; Huang YJ; Wang CY; Wang CJ
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):123-8. PubMed ID: 22672751
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone.
    Mabuchi S; Ugaki H; Isohashi F; Yoshioka Y; Temma K; Yada-Hashimoto N; Takeda T; Yamamoto T; Yoshino K; Nakajima R; Kuragaki C; Morishige K; Enomoto T; Inoue T; Kimura T
    Gynecol Obstet Invest; 2010; 69(4):224-232. PubMed ID: 20068328
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. High dose rate intraoperative radiotherapy for recurrent cervical cancer and nodal disease.
    Roth TM; Secord AA; Havrilesky LJ; Jones E; Clarke-Pearson DL
    Gynecol Oncol; 2003 Oct; 91(1):258-60. PubMed ID: 14529691
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Pelvic wall recurrence of cervix carcinomas. Combined surgical-radio-chemotherapeutic procedure (CORCT)].
    Schulz-Wendtland R; Krämer S; Säbel M; Heller F; Keilholz L; Jäger W; Sauer R; Lang N; Bautz W
    Strahlenther Onkol; 1998 May; 174(5):279-83. PubMed ID: 9614958
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. High-dose-rate afterloading brachytherapy, external radiation therapy, and combination chemotherapy in poor-prognosis cancer of the cervix.
    Malviya VK; Han I; Deppe G; Malone JM; Christensen CW; Kim Y; Ahmad K
    Gynecol Oncol; 1991 Sep; 42(3):233-8. PubMed ID: 1955185
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.